567 related articles for article (PubMed ID: 10482687)
1. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience.
Morris-Stiff G; Bhati C; Olliff S; Hübscher S; Gunson B; Mayer D; Mirza D; Buckels J; Bramhall SR
Dig Surg; 2008; 25(2):126-32. PubMed ID: 18446034
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
4. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
[TBL] [Abstract][Full Text] [Related]
5. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
Siqueira E; Schoen RE; Silverman W; Martin J; Rabinovitz M; Weissfeld JL; Abu-Elmaagd K; Madariaga JR; Slivka A
Gastrointest Endosc; 2002 Jul; 56(1):40-7. PubMed ID: 12085033
[TBL] [Abstract][Full Text] [Related]
6. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
7. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.
Björnsson E; Kilander A; Olsson R
Liver; 1999 Dec; 19(6):501-8. PubMed ID: 10661684
[TBL] [Abstract][Full Text] [Related]
8. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Charatcharoenwitthaya P; Lindor KD
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
[No Abstract] [Full Text] [Related]
11. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
12. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].
Yuan J; Han GH
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease.
Deneau M; Adler DG; Schwartz JJ; Hutson W; Sorensen J; Book L; Lowichik A; Guthery S
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):617-20. PubMed ID: 21502832
[No Abstract] [Full Text] [Related]
14. A localized primary sclerosing cholangitis preoperatively diagnosed as hilar cholangiocarcinoma; report of a case.
Kojima T; Shimura T; Takahashi M; Haga N; Hashimoto S; Fukuda T; Kuwano H
Hepatogastroenterology; 2004; 51(58):961-3. PubMed ID: 15239224
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for primary sclerosing cholangitis.
Sekido H; Takeda K; Morioka D; Kubota T; Tanaka K; Endo I; Nagahori K; Togo S; Shimada H
J Hepatobiliary Pancreat Surg; 1999; 6(4):373-6. PubMed ID: 10664284
[TBL] [Abstract][Full Text] [Related]
16. Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.
Rungsakulkij N; Sornmayura P; Tannaphai P
BMC Surg; 2017 Feb; 17(1):17. PubMed ID: 28202062
[TBL] [Abstract][Full Text] [Related]
17. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
Hultcrantz R; Olsson R; Danielsson A; Järnerot G; Lööf L; Ryden BO; Wahren B; Broomé U
J Hepatol; 1999 Apr; 30(4):669-73. PubMed ID: 10207809
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis.
Wannhoff A; Gotthardt DN
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):236-243. PubMed ID: 30266579
[TBL] [Abstract][Full Text] [Related]
19. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-2003. A 14-year-old boy with ulcerative colitis, primary sclerosing cholangitis, and partial duodenal obstruction.
Ross AM; Anupindi SA; Balis UJ
N Engl J Med; 2003 Apr; 348(15):1464-76. PubMed ID: 12686704
[No Abstract] [Full Text] [Related]
20. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
